Qilu Pharmaceutical Research and Development Center

Qilu Pharmaceutical is a leading vertically integrated Chinese pharmaceutical company engaged in the development, manufacturing, and commercialization of generic and innovative drugs. The Qilu Pharmaceutical Research and Development Center serves as the company's core innovation engine, focusing on high-value therapeutics across oncology, infectious diseases, and metabolic disorders. The company maintains a robust pipeline of small molecules, biologics, and biosimilars, with a growing emphasis on novel immunotherapies and bispecific antibodies developed via its proprietary MabPair platform. With a global footprint including R&D hubs in China and the United States, Qilu provides comprehensive healthcare solutions ranging from active pharmaceutical ingredients to finished dosage forms. The company is recognized as one of the largest pharmaceutical entities in China by both revenue and R&D investment.